阿尔茨海默病的进激素和神经病理特征:纵向研究
Fardin Nabizadeh1,2, Rasa Zafari3,
1School of Medicine, Iran University of Medical Sciences, Tehran, Iran. fardinnabizade1378@gmail.com.
Aging clinical and experimental research
|March 5, 2024
概括
脑脊液中增加的progranulin水平与只有tau病理的个体中更快的粉样β斑块形成有关,这表明阿尔茨海默氏症在疾病进展中发挥了依赖阶段的作用.
科学领域:
- 神经科学是一个神经科学.
- 生物化学 生物化学
- 病理学 病理学 病理学
背景情况:
- 益格拉努林是一种抗炎蛋白,对神经元功能和中枢神经系统的维护至关重要.
- 在阿尔茨海默氏病 (AD) 患者中观察到脑脊液 (CSF) 进激素水平升高,这与粉样β (Aβ) 和沉积有关.
- 了解在AD的病理生理学谱中progranulin的动态作用是必不可少的.
研究的目的:
- 为了研究不同AD病理生理阶段的CSF前列腺素水平的纵向变化.
- 探索CSF前列腺素动态与AD相关的病理特征之间的关联.
主要方法:
- 分析了ADNI数据库中的1001名参与者的CSF和神经成像数据.
- 使用A/T/N框架 (Aβ,Tau,神经退行) 将参与者分为四组.
主要成果:
- 在A/T/N组 (P=0.001) 中观察到CSF前列腺素水平的显著差异.
- 脑流中的变化率与基线Aβ-PET和Aβ-PET变化率相关,特别是在A-/TN+组 (疑似非阿尔茨海默氏症病理).
结论:
- 随着时间的推移,脑流中的前列蛋白增加与患有突发性tau病理的个体中加速的Aβ斑块形成有关.
- 普罗格拉努林对AD病理学的影响似乎取决于阶段,并且在非AD的病理变化中可能更为显著.
- 对阿尔茨海默病的基于progranulin的治疗方法进行进一步的研究是有必要的.
相关概念视频
Alzheimer's Disease: Overview
481
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
481
Neural Regulation
39.4K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.4K
Amyloid Fibrils
9.5K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.5K


